| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.500 | None | 1.000 | 4 | 3 | 2009 | 2019 | ||||||||
|
CD247 molecule | 0.539 | 0.731 | 1.7E-02 |
|
disease | 0.460 | None | 0.875 | 2 | 1 | 1998 | 2019 | ||||||||
|
TNFAIP3 interacting protein 1 | 0.564 | 0.769 | 0.48 |
|
disease | 0.440 | None | 0.857 | 2 | 2 | 2011 | 2019 | ||||||||
|
psoriasis susceptibility 1 candidate 1 | 0.656 | 0.731 | 2.7E-04 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2011 | 2013 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.180 | None | 1.000 | 2 | 3 | 1996 | 2017 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.120 | None | 1.000 | 2 | 3 | 2010 | 2016 | ||||||||
|
integrin subunit alpha M | 0.443 | 0.808 | 3.3E-11 |
|
disease | 0.120 | None | 1.000 | 1 | 3 | 2011 | 2013 | ||||||||
|
PX domain containing serine/threonine kinase like | 0.821 | 0.231 | 1.1E-02 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2013 | 2019 | ||||||||
|
SRY-box transcription factor 5 | 0.545 | 0.769 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
JAZF zinc finger 1 | 0.582 | 0.654 | 0.90 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
KIAA0319 like | 0.711 | 0.423 | 1.2E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
interleukin 12 receptor subunit beta 2 | 0.608 | 0.692 | 1.6E-09 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
mutS homolog 5 | 0.641 | 0.692 | 3.2E-11 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
apoptosis and caspase activation inhibitor | 0.760 | 0.231 | 2.7E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
PHD and ring finger domains 1 | 0.743 | 0.346 | 5.7E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene) | 0.780 | 0.538 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2009 | |||||||||
|
mucin 22 | 0.729 | 0.500 | 1.4E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2010 | 2010 | ||||||||
|
leucine rich melanocyte differentiation associated | 0.659 | 0.577 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
zinc finger CCCH-type containing 10 | 1.000 | 0.038 | 0.32 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
serine/threonine kinase 19 | 0.691 | 0.500 | 6.7E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
heat shock protein family A (Hsp70) member 1 like | 0.603 | 0.654 | 1.1E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
long intergenic non-protein coding RNA 1500 | 0.760 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 |